Differentiating solitary brain metastases from high-grade gliomas with MR: comparing qualitative versus quantitative diagnostic strategies

[1] Law M(2002)High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging Radiology 222 715-721

[2] Cha S(2005)Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987-996

[3] Knopp EA(2016)The 2016 World Health Organization classification of tumors of the central nervous system: a summary Acta Neuropathol 131 803-820

[4] Stupp R(2007)Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging Am J Neuroradiol 28 1078-1084

[5] Mason WP(2014)Treatment of single or multiple brain metastases by hypofractionated stereotactic radiotherapy using helical tomotherapy Int J Mol Sci 15 6910-6924

[6] van den Bent MJ(2012)Multiparametric magnetic resonance imaging to differentiate high-grade gliomas and brain metastases J Neuroradiol 39 301-307

[7] Louis DN(2012)Cerebral peritumoral oedema study: does a single dynamic MR sequence assessing perfusion and permeability can help to differentiate glioblastoma from metastasis? Eur J Radiol 81 522-527

[8] Perry A(2015)Differentiation of solitary brain metastasis from glioblastoma multiforme: a predictive multiparametric approach using combined MR diffusion and perfusion Neuroradiology 57 697-703

[9] Reifenberger G(2014)Gradient of apparent diffusion coefficient values in peritumoral edema helps in differentiation of glioblastoma from solitary metastatic lesions Am J Roentgenol 203 163-169

[10] Cha S(2011)Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions Am J Roentgenol 196 71-76

[1] Law M(2002)High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging Radiology 222 715-721

[2] Cha S(2005)Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987-996

[3] Knopp EA(2016)The 2016 World Health Organization classification of tumors of the central nervous system: a summary Acta Neuropathol 131 803-820

[4] Stupp R(2007)Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging Am J Neuroradiol 28 1078-1084

[5] Mason WP(2014)Treatment of single or multiple brain metastases by hypofractionated stereotactic radiotherapy using helical tomotherapy Int J Mol Sci 15 6910-6924

[6] van den Bent MJ(2012)Multiparametric magnetic resonance imaging to differentiate high-grade gliomas and brain metastases J Neuroradiol 39 301-307

[7] Louis DN(2012)Cerebral peritumoral oedema study: does a single dynamic MR sequence assessing perfusion and permeability can help to differentiate glioblastoma from metastasis? Eur J Radiol 81 522-527

[8] Perry A(2015)Differentiation of solitary brain metastasis from glioblastoma multiforme: a predictive multiparametric approach using combined MR diffusion and perfusion Neuroradiology 57 697-703

[9] Reifenberger G(2014)Gradient of apparent diffusion coefficient values in peritumoral edema helps in differentiation of glioblastoma from solitary metastatic lesions Am J Roentgenol 203 163-169

[10] Cha S(2011)Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions Am J Roentgenol 196 71-76